Blocking Opioid Receptors Could Rebalance Dopamine Levels
New research suggests that blocking kappa opioid receptors (KOR) can restore normal dopamine signaling in mouse models with a rare mutation, offering a potential safer treatment for disorders like ADHD, autism, and bipolar disorder by targeting dopamine imbalances without the side effects of current therapies.